FDA staff reviewers blasted rosiglitazone (Avandia) in briefing documents released Friday, recommending that the diabetes drug be yanked from the market because of the "serious" cardiovascular risks it poses.
Meanwhile, in a move that angered Republicans, President Obama used a recess appointment to install Don Berwick, MD, as the administrator for the Centers for Medicare and Medicaid Services (CMS).



